AN ACT ADDRESSING PATIENTS' PRESCRIPTION DRUG COSTS.

HB 6870 creates a process for the state to potentially import prescription drugs from Canada to lower costs for residents. It requires the Department of Consumer Protection to study the feasibility of such a program by October 2027, then seek federal approval for the program if the study finds it viable. If approved by federal regulators, participating wholesalers could import and distribute eligible drugs meeting safety and federal tracing requirements, directly affecting patients seeking affordable medications. The bill does not implement the program itself but establishes the framework for future action.